title: Effect of fenofibrate on apolipoprotein B containing lipoprotein particles.
authors.affiliation: SERLIA, Institut Pasteur, Lille, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Fruchart
authors.forename: J M
authors.initials: JM
authors.lastname: Bard
authors.forename: C
authors.initials: C
authors.lastname: Fievet
authors.forename: A
authors.initials: A
authors.lastname: Kandoussi
authors.forename: M
authors.initials: M
authors.lastname: Slimane
authors.forename: P
authors.initials: P
authors.lastname: Douste-Blazy
mesh_terms: D001055:Apolipoproteins B / Q000097:blood*; D004311:Double-Blind Method; D005260:Female; D011345:Fenofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007124:Immunoenzyme Techniques; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D011422:Propionates / Q000627:therapeutic use*; D011897:Random Allocation
chemical_list: D001055:Apolipoproteins B; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D011422:Propionates; C006012:fenofibric acid; D011345:Fenofibrate